FDD Conclave 2025

The inaugural session of FDD Conclave 2025 set a powerful tone for the twoday event that united the industry’s brightest minds in…

The final panel discussion on Day 2 of the FDD Conclave 2025 focused on how formulation science can evolve to better serve special…

Drug delivery is undergoing a transformation driven by the demand for patient-friendly, painfree alternatives. As pharma R&D…

As the push for non-invasive, patient-centric treatment options intensifies, topical and transdermal drug delivery systems are…

Day two at the FDD Conclave 2025 began with a highly insightful and motivating keynote address by Dr Pavan Bhat, CEO, Inventia…

The seventh edition of the FDD Leadership Awards, and held alongside the FDD Conclave 2025, continued to uphold its legacy of…

The panel discussion titled ‘Biologics and Biosimilars: The Next Leap in Patient-Centric Drug Development’ at the FDD Conclave…

At the FDD Conclave 2025, Akil Kadiyavala, GM - Technical Services, Dhara Lifescience presented a compelling case for adopting…

Managing nitrosamines that form during manufacturing and storage, due to reactions between nitrites and amine-containing APIs or…

At the FDD Conclave 2025, Abhishek Ghongade, Deputy Sales Manager, and Chetan Chennur, Sales & Project Management, from Harro…